FDA Approved: ORAVIG — Original Application (Galt Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves ORAVIG (miconazole) under an original NDA from Galt Pharmaceuticals, LLC for the treatment of oropharyngeal candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Candidiasis

Drugs mentioned

• ORAVIG (MICONAZOLE)

Snippet

ORIG AP for ORAVIG (MICONAZOLE)